Clinical trialNCT05592626RecruitingPhase 1/PHASE2Interventional

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

SponsorMarengo Therapeutics, Inc.Enrollment365Abdominal NeoplasmAdvanced Solid TumorsCarcinomaEpstein-Barr Virus InfectionsGenital Neoplasm, FemaleLung Neoplasm+6 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Lillian Siu, MD
Recruiting
Research Institute of Mcgill University Health Centre
Montreal, Quebec, Canada
Ramy Saleh, MD
Recruiting

France

Hopsital Institut Curie
Paris, France, France
Christophe Le Tourneau, MD, PhD
Recruiting
Oncopole Claudius Regaud Iuct
Toulouse, France, France
Carlos Gomez-Roca, MD
Recruiting
Institut Bergonié
Bordeaux, France
Antoine Italiano, MD
Recruiting
Centre Leon Berard
Lyon, France
Philippe Cassier, MD
Recruiting
Institute Gustave Roussy
Villejuif, France
Aurelien Marabelle, MD
Recruiting

Spain

Vall D'Hebron Institute of Oncology
Barcelona, Catalonia, Spain
Elena Garralda, MD
Recruiting
Clinica Universidad de Navarra
San Blas-Canillejas, Madrid, Spain
Eduardo Castanon, MD
Recruiting
Hospital Universitario Quirónsalud Madrid
Madrid, Spain, Spain
Valentina Boni, MD
Recruiting
Next Oncology Barcelona, Hospital Quirónsalud Barcelona
Barcelona, Spain
Omar Saavedra, MD
Recruiting
Start Madrid Fjd
Madrid, Spain
Manuel Pedregal, MD
Recruiting
Clinica Universidad de Navarra
Pamplona, Spain
Eduardo Castanon, MD
Recruiting
Instituto de Investigacion Sanitaria, Incliva
Valencia, Spain
Susana Roselló, MD
Recruiting

United States

Loma Linda University Cancer Center
Loma Linda, California, United States
John Shin, MD
Recruiting
Uc Davis Comprehensive Cancer Center
Sacramento, California, United States
Tianhong Li, MD
Recruiting
Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
Jason Henry, MD
Recruiting
Adventhealth Celebration
Celebration, Florida, United States
Guru Sonpavde, MD
Recruiting
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Marijo Billusic, MD
Recruiting
the University of Kansas Cancer Center
Kansas City, Kansas, United States
Weijing Sun, MD
Recruiting
National Institutes of Health
Bethesda, Maryland, United States
James Gulley, MD, PhD
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Ann Silk, MD
Recruiting
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Ryan Sullivan, MD
Recruiting
Karmanos Cancer Institute
Detroit, Michigan, United States
Wasif Saif, MD
Recruiting
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Gopa Iyer, MD
Recruiting
the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Kai He, MD
Recruiting
University of Oklahoma Health Sciences, Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Abdul R Naqash, MD
Recruiting
Sarah Cannon Research Institute Oncology Partners (scri-Nashville)
Nashville, Tennessee, United States
Meredith Pelster, MD
Recruiting
the University of Texas, Md Anderson Cancer Center
Houston, Texas, United States
Stephane Champiat, MD
Recruiting
Ut Health Mays Cancer Center
San Antonio, Texas, United States
Sukeshi Patel Arora, MD
Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Diane Tseng, MD
Recruiting
University of Wisconsin- Madison
Madison, Wisconsin, United States
Vincent Ma, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

STAR0602 →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 Jan 2023
Primary completion: 31 Oct 2026
Completion: 31 Oct 2026
Last update posted: 9 Jul 2025
Registered enrollment: 365
Registry id: NCT05592626

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.